A previous study showed that systemic administration of CSF1 accelerates disease progression in the SOD1G37R mouse, suggesting that overactivation of CSF1R exerts detrimental actions in ALS, probably, by increasing the mitogenic activity of microglia18, 19. Here, CSF1R is linked to amyotrophic lateral sclerosis.